BCM
CORV

Beryl Capital Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Beryl Capital Management’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,380,663
Closed -$924K – 75
2020
Q1 		$924K Buy
+2,380,663
New +$861K 0.19% 29

Beryl Capital Management's CORV Position: Q2 2020 in Review

Beryl Capital Management sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2020, closing a stake of 2,380,663 shares — an estimated $924K sold.

Beryl Capital Management first reported a position in CORV in Q1 2020 and held it in 1 quarter. The position peaked at $924K in Q1 2020. 0 funds tracked by Wall St. Rank hold CORV as of Q2 2020.

  • Beryl Capital Management reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2020 after selling out during the quarter.
  • Beryl Capital Management sold 2,380,663 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2020, an estimated $924K.
  • Beryl Capital Management first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q1 2020 and held it in 1 quarter.
  • Beryl Capital Management's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $924K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2020.

Based on Beryl Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.